Gene · 8553
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative genomic analysis and diagnostic modeling of osteoporosis: unraveling the interplay of autophagy, osteogenesis, adipogenesis, and immune infiltration. | Front Med (Lausanne) | 2025 | 40313558 | PubTator, text mining | PubMed |
| Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance. | Semin Oncol | 2025 | 40250076 | PubTator, text mining | PubMed |
| Identification of BHLHE40-Expressing CD4+ T Cells Producing GM-CSF in Rheumatoid Arthritis. | Int J Rheum Dis | 2025 | 40223427 | PubTator, text mining | PubMed |
| Abstracts of the 35th Meeting of the German Society for Pediatric and Adolescents Rheumatology (Gesellschaft für Kinder- und Jugendrheumatology (GKJR). | Pediatr Rheumatol Online J | 2025 | 40098132 | PubTator, text mining | PubMed |
| Coordinated macrophage and T cell interactions mediate response to checkpoint blockade in colorectal cancer. | bioRxiv | 2025 | 40027748 | PubTator, text mining | PubMed |
| Modeling and designing enhancers by introducing and harnessing transcription factor binding units. | Nat Commun | 2025 | 39922842 | PubTator, text mining | PubMed |
| An Assessment of BHLHE40 Transcription Factor Level and its Target Cytokines in Patients with Rheumatoid Arthritis. | Recent Adv Inflamm Allergy Drug Discov | 2025 | 39917914 | PubTator, text mining | PubMed |
| [Knockdown of BHLHE40 inhibits the proliferation, migration, invasion and PI3K/AKT signaling activity of osteosarcoma cells]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2025 | 39799423 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomics reveals subsets of degenerative myonuclei after rotator cuff tear-induced muscle atrophy. | Cell Prolif | 2025 | 39435630 | PubTator, text mining | PubMed |
| Single-Cell Data Analysis Reveals Critical Hepatic Cells Subpopulations in the Progression of Non-alcoholic Fatty Liver Disease to Non-Alcoholic Steatohepatitis. | Comb Chem High Throughput Screen | 2025 | 38803181 | PubTator, text mining | PubMed |
| MetArea: a software package for analysis of the mutually exclusive occurrence in pairs of motifs of transcription factor binding sites based on ChIP-seq data. | Vavilovskii Zhurnal Genet Selektsii | 2024 | 39944799 | PubTator, text mining | PubMed |
| Advancements in the Application of scRNA-Seq in Breast Research: A Review. | Int J Mol Sci | 2024 | 39769466 | PubTator, text mining | PubMed |
| Pathway metrics accurately stratify T cells to their cells states. | BioData Min | 2024 | 39716187 | PubTator, text mining | PubMed |
| Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence. | Cell Commun Signal | 2024 | 39668349 | PubTator, text mining | PubMed |
| BHLHE40-mediated transcriptional activation of GRIN2D in gastric cancer is involved in metabolic reprogramming. | Funct Integr Genomics | 2024 | 39546079 | PubTator, text mining | PubMed |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. | Nat Cancer | 2024 | 39478117 | PubTator, text mining | PubMed |
| Modulation of Neuronal Excitability and Plasticity by BHLHE41 Conveys Lithium Non-Responsiveness. | bioRxiv | 2024 | 39372797 | PubTator, text mining | PubMed |
| Circadian gene signatures in the progression of obesity based on machine learning and Mendelian randomization analysis. | Front Nutr | 2024 | 39351493 | PubTator, text mining | PubMed |
| Dimension reduction, cell clustering, and cell-cell communication inference for single-cell transcriptomics with DcjComm. | Genome Biol | 2024 | 39252099 | PubTator, text mining | PubMed |
| Computational Analyses Reveal Deregulated Clock Genes Associated with Breast Cancer Development in Night Shift Workers. | Int J Mol Sci | 2024 | 39201344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8553/papers?page=5